Literature DB >> 1905017

An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins.

J Yen1, R M Wisdom, I Tratner, I M Verma.   

Abstract

Two forms of FosB transcript and their products can be identified in mouse NIH 3T3 cells following serum induction. The larger RNA codes for a 338-amino acid protein, whereas the smaller RNA results from the removal of an additional 140 nucleotides from FosB mRNA by alternative splicing. This alternative splicing event places a stop codon following the "leucine zipper" region and results in a shorter protein (FosB2) of 237 amino acids that lacks 101 amino acids at the carboxyl terminus. FosB2 is able to form heterodimers with c-Jun and bind to an AP-1 site but is not able to activate the transcription of promoters containing AP-1 sites. Furthermore, FosB2 can not only suppress the transcriptional activation by c-Fos and c-Jun of promoters containing an AP-1 site but also interferes with the transforming potential of viral and cellular Fos proteins. We propose that FosB2 protein functions as a trans-negative regulator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905017      PMCID: PMC51814          DOI: 10.1073/pnas.88.12.5077

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.

Authors:  L J Ransone; J Visvader; P Sassone-Corsi; I M Verma
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

2.  Rapid and simple amplification of a specific RNA sequence by the polymerase chain reaction.

Authors:  D R Sherman; J Geliebter; G A Cross
Journal:  Trends Genet       Date:  1989-05       Impact factor: 11.639

3.  The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain.

Authors:  N Mermod; E A O'Neill; T J Kelly; R Tjian
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

4.  jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

Authors:  J Schütte; J Viallet; M Nau; S Segal; J Fedorko; J Minna
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

5.  trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation.

Authors:  F C Lucibello; C Lowag; M Neuberg; R Müller
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

6.  Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers.

Authors:  R Turner; R Tjian
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

7.  The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes.

Authors:  D R Cohen; P C Ferreira; R Gentz; B R Franza; T Curran
Journal:  Genes Dev       Date:  1989-02       Impact factor: 11.361

8.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

9.  The basic region of Fos mediates specific DNA binding.

Authors:  Y Nakabeppu; D Nathans
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

Authors:  M Zerial; L Toschi; R P Ryseck; M Schuermann; R Müller; R Bravo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  48 in total

Review 1.  DeltaFosB: a sustained molecular switch for addiction.

Authors:  E J Nestler; M Barrot; D W Self
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Control of excision frequency of maize transposable element Ds in Petunia protoplasts.

Authors:  D Becker; R Lütticke; M Li; P Starlinger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Changes in activating protein 1 (AP-1) composition correspond with the biphasic profile of nerve growth factor mRNA expression in rat hippocampus after hilus lesion-induced seizures.

Authors:  R C Elliott; C M Gall
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

4.  Absence of a persistently elevated 37 kDa fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice.

Authors:  A Mandelzys; M A Gruda; R Bravo; J I Morgan
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

5.  Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures.

Authors:  N Hiroi; G J Marek; J R Brown; H Ye; F Saudou; V A Vaidya; R S Duman; M E Greenberg; E J Nestler
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

6.  Fos family members induce cell cycle entry by activating cyclin D1.

Authors:  J R Brown; E Nigh; R J Lee; H Ye; M A Thompson; F Saudou; R G Pestell; M E Greenberg
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.

Authors:  L J Ransone; L D Kerr; M J Schmitt; P Wamsley; I M Verma
Journal:  Gene Expr       Date:  1993

8.  Antisense rescue defines specialized and generalized functional domains for c-Fos protein.

Authors:  J T Holt
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential.

Authors:  I Tratner; R Ofir; I M Verma
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

Authors:  F B Furnari; V Zacny; E B Quinlivan; S Kenney; J S Pagano
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.